Ferumoxytol

CHEMBL1201867 Phase 4 Zugelassen Unknown
Half-Life
Bioavailability
Protein Binding
Molecular Weight
231.5 g/mol
LogP
Phase
4

This injectable iron oxide nanoparticle preparation is used to treat iron deficiency anemia in adults with chronic kidney disease or other conditions who cannot tolerate or absorb oral iron. It can also serve as an MRI contrast agent due to its magnetic properties.

Molekularmasse

231,5300 g/mol

TPSA

4,00 Ų

Therapeutische Bereiche

Wirkmechanismus

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanismus

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3]

InChI

InChI=1S/3Fe.4O/q+2;2*+3;4*-2

Molecular Formula

Fe3O4

HBD / HBA

- / 4

Rotierbare Bindungen

0

Schwere Atome

7

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

This injectable iron oxide nanoparticle preparation is used to treat iron deficiency anemia in adults with chronic kidney disease or other conditions who cannot tolerate or absorb oral iron. It can also serve as an MRI contrast agent due to its magnetic properties.

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Yes, Ferumoxytol is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201867. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6432052. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.